1. Home
  2. EXEL vs LBRDP Comparison

EXEL vs LBRDP Comparison

Compare EXEL & LBRDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • LBRDP
  • Stock Information
  • Founded
  • EXEL 1994
  • LBRDP N/A
  • Country
  • EXEL United States
  • LBRDP United States
  • Employees
  • EXEL N/A
  • LBRDP 1900
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • LBRDP Cable & Other Pay Television Services
  • Sector
  • EXEL Health Care
  • LBRDP Telecommunications
  • Exchange
  • EXEL Nasdaq
  • LBRDP Nasdaq
  • Market Cap
  • EXEL 9.8B
  • LBRDP N/A
  • IPO Year
  • EXEL 2000
  • LBRDP N/A
  • Fundamental
  • Price
  • EXEL $36.17
  • LBRDP $24.40
  • Analyst Decision
  • EXEL Buy
  • LBRDP
  • Analyst Count
  • EXEL 18
  • LBRDP 0
  • Target Price
  • EXEL $37.59
  • LBRDP N/A
  • AVG Volume (30 Days)
  • EXEL 2.2M
  • LBRDP N/A
  • Earning Date
  • EXEL 05-13-2025
  • LBRDP N/A
  • Dividend Yield
  • EXEL N/A
  • LBRDP N/A
  • EPS Growth
  • EXEL 170.77
  • LBRDP N/A
  • EPS
  • EXEL 1.76
  • LBRDP N/A
  • Revenue
  • EXEL $2,168,701,000.00
  • LBRDP N/A
  • Revenue This Year
  • EXEL $5.78
  • LBRDP N/A
  • Revenue Next Year
  • EXEL $10.94
  • LBRDP N/A
  • P/E Ratio
  • EXEL $20.64
  • LBRDP N/A
  • Revenue Growth
  • EXEL 18.50
  • LBRDP N/A
  • 52 Week Low
  • EXEL $20.14
  • LBRDP N/A
  • 52 Week High
  • EXEL $40.26
  • LBRDP N/A
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 43.89
  • LBRDP 52.01
  • Support Level
  • EXEL $34.90
  • LBRDP $24.35
  • Resistance Level
  • EXEL $40.26
  • LBRDP $24.59
  • Average True Range (ATR)
  • EXEL 1.21
  • LBRDP 0.22
  • MACD
  • EXEL -0.19
  • LBRDP 0.05
  • Stochastic Oscillator
  • EXEL 23.69
  • LBRDP 67.80

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

Share on Social Networks: